Yu Aili, Huang Zhiqing, Shi Hang, Lin Yanying, Cai Xuefen, Ke Zhanghong, Zheng Beihong, Sun Yan
Center of Reproductive Medicine, Fujian Maternity and Child Health Hospital, Fuzhou, 350001, China.
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, China.
Biochem Biophys Rep. 2024 Nov 22;40:101886. doi: 10.1016/j.bbrep.2024.101886. eCollection 2024 Dec.
The aim of this study was to investigate the genetic factors of a patient with germinal vesicle arrest in oocytes. Clinical data and blood samples were collected from the patient and some were amplified for high-throughput gene and Sanger sequencing. Several molecular and cellular experiments were performed to determine the association between the gene mutation and germinal vesicle arrest. Two mutation sites (c.1282G > T and c.1247C > A) were found in the gene. The c.1282G > T mutation is associated with oocyte maturation abnormalities according to previous research, whereas c.1247C > A is a novel mutation of unknown clinical significance. In cell transfection experiments, qRT-PCR, immunofluorescence, and Western blotting revealed that the mRNA and protein levels of the gene with the c.1247C > A mutation were reduced. Sanger sequencing suggested that the patient inherited the mutations from her parents via a compound heterozygous mode of inheritance. Collectively, this study describes the -gene c.1247C > A mutation associated with germinal vesicle arrest in oocytes, providing a useful target for genetic and background tests for patients presenting with oocyte maturation abnormalities and/or germinal vesicle arrest following multiple unsuccessful attempts with assisted reproductive technology.
本研究旨在探究一名卵母细胞生发泡停滞患者的遗传因素。收集了该患者的临床资料和血液样本,其中部分样本进行了高通量基因扩增和桑格测序。进行了多项分子和细胞实验,以确定基因突变与生发泡停滞之间的关联。在该基因中发现了两个突变位点(c.1282G>T和c.1247C>A)。根据先前的研究,c.1282G>T突变与卵母细胞成熟异常有关,而c.1247C>A是一个临床意义未知的新突变。在细胞转染实验中,qRT-PCR、免疫荧光和蛋白质免疫印迹结果显示,携带c.1247C>A突变的该基因的mRNA和蛋白质水平降低。桑格测序表明,该患者通过复合杂合子遗传模式从其父母那里继承了这些突变。总的来说,本研究描述了与卵母细胞生发泡停滞相关的该基因突变,为在辅助生殖技术多次尝试失败后出现卵母细胞成熟异常和/或生发泡停滞的患者进行基因和背景检测提供了一个有用的靶点。